Literature DB >> 10767722

Up-regulation of inducible nitric oxide synthase in fibroblasts parallels the onset and progression of fibrosis in an experimental model of post-transplant obliterative airway disease.

H M Romanska1, T S Ikonen, A E Bishop, R E Morris, J M Polak.   

Abstract

The main cause of mortality following lung transplantation is chronic rejection, manifesting morphologically as obliterative bronchiolitis (OB). It has been suggested that damage to the respiratory epithelium initiates proliferation of mesenchymal cells, leading to dense collagenous scarring in small airways. Inducible nitric oxide synthase (iNOS) is strongly expressed in the damaged epithelium in human OB, along with high levels of peroxynitrite, suggesting that endogenous NO mediates the epithelial destruction. To examine further the role of iNOS in this process, heterotopic airway implants were studied in rats, an acknowledged disease model. Specimens of iso- or allografted trachea, collected 3-60 days after implantation, were processed for histology and immunocytochemistry for iNOS and, as a marker of peroxynitrite formation, nitrotyrosine. In both iso- and allografts at the earliest stage (day 3), ischaemia was associated with severe epithelial damage or loss. These changes progressed until day 7 and were accompanied by strong expression of iNOS and nitrotyrosine in epithelial cells. In isografts, epithelial recovery was seen, with abundant iNOS immunoreactivity but little nitrotyrosine. In contrast, the epithelium in allografts did not regenerate and progressive inflammation and fibroproliferation occurred until complete obliteration of the tracheal lumen at day 60. The fibroproliferation was associated with changes in morphology of fibroblasts that were accompanied by alterations in their iNOS expression. iNOS immunoreactivity was dense in the plump fibroblasts of early lesions, in some cases as early as post-operative day 5, but very weak in elongated fibroblasts in totally occluded grafts. The intensity of immunoreactivity for nitrotyrosine corresponded to that of iNOS. These results indicate a dual role for NO in the airway obliteration that follows transplantation, through destruction of epithelium and stimulation of fibroblast activity. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10767722     DOI: 10.1002/(SICI)1096-9896(200005)191:1<71::AID-PATH560>3.0.CO;2-I

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  6 in total

1.  Bronchiolitis obliterans induced by intratracheal papaverine: a novel animal model.

Authors:  J Svetlecic; A Molteni; B Herndon
Journal:  Lung       Date:  2004       Impact factor: 2.584

2.  Effects of quercetin on liver damage in rats with carbon tetrachloride-induced cirrhosis.

Authors:  Amalia Pavanato; María J Tuñón; Sonia Sánchez-Campos; Claudio A Marroni; Susana Llesuy; Javier González-Gallego; Norma Marroni
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

3.  Mycophenolic acid inhibits activation of inducible nitric oxide synthase in rodent fibroblasts.

Authors:  Dj Miljkovic; I Cvetkovic; S Stosic-Grujicic; V Trajkovic
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

Review 4.  The heterotopic tracheal allograft as an animal model of obliterative bronchiolitis.

Authors:  D J Hele; M H Yacoub; M G Belvisi
Journal:  Respir Res       Date:  2001-04-05

Review 5.  Sauropus androgynus (L.) Merr. Induced Bronchiolitis Obliterans: From Botanical Studies to Toxicology.

Authors:  Hamidun Bunawan; Siti Noraini Bunawan; Syarul Nataqain Baharum; Normah Mohd Noor
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-27       Impact factor: 2.629

6.  CB1 R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky-Pudlak syndrome.

Authors:  Resat Cinar; Joshua K Park; Charles N Zawatsky; Nathan J Coffey; Steven P Bodine; Jasmina Abdalla; Tadafumi Yokoyama; Tony Jourdan; Lindsey Jay; Mei Xing G Zuo; Kevin J O'Brien; Junfeng Huang; Ken Mackie; Asaf Alimardanov; Malliga R Iyer; William A Gahl; George Kunos; Bernadette R Gochuico; May Christine V Malicdan
Journal:  Clin Transl Med       Date:  2021-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.